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Abstract. Empirical measures of ‘decision aid quality’, like normative ones, are of 
a formative construct and therefore embody interest-conflicted preferences in their 
criteria selection and weighting. The preferences of the International Patient 
Decision Aid Standards consortium distinguish the quality of the decision-making 
process and the quality of the choice that is made ‘(i.e., decision quality)’. The 
Decision Conflict Scale features heavily in their profile measure of the former and 
Decision Quality Instruments (DQIs), have been developed by members of the 
consortium to measure the latter. We confirm that both of these, and other 
components, like the higher-level measures, are preference-sensitive and interest-
conflicted. Non-financial interest-conflicted preferences are endemic in healthcare 
research, policy-making, and practice. That they are inevitable means the main 
problem lies in the denial of this and attitude to and behaviour towards 
alternatives, equally interest-conflicted. 
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1. Introduction 
In the companion paper [1] it was established that quality is a formative construct and 
measures of it are therefore preference-sensitive. They are sensitive to the preferences 
involved in the selection of the component scales (items) and to the weights used to 
aggregate those scales into an index measure. The measurement of the quality of a 
decision aid is no exception. The popular International Patient Decision Aid Standards 
measure, with its proposed ‘certification’ standard, reflects the preferences emerging 
from the consortium responsible for its development and maintenance. It was also 
established that, given the expanded definition of ‘interest’ relevant in healthcare 
research and provision, which include commitments to particular theoretical, 
methodological and ethical frameworks, institutional practices and schools of thought 
[2], the IPDASi measure is interest-conflicted. However, it was emphasised that this 
applies to all related measures, so the only possible objections can be to failure to 
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acknowledge the formative ontology of the measure, to attempts to establish the 
measure as a ‘gold standard’, and to criticism of alternatives on the ground that they 
reflect interest-conflicted preferences.  
In this paper we focus on the empirical measurement of the quality of decision aids 
as implemented. We make clear from the outset here that our overriding preference is 
to avoid all normative measures, whether IPDASi or ones based on alternative interest-
based preferences. Normative considerations should exert influence, but only via 
empirical outcome quality constructs, not independently or a priori. Notwithstanding, 
empirical measures, like normative measures, are of some formative construct of 
decision aid quality, so the task is again to demonstrate that they embody interest-
conflicted preferences through their criteria selection and weighting. Conceptually, 
these alternatives will be measures of different constructs of decision aid quality rather 
than different measures of decision aid quality, which does not exist until it is formed. 
While we again focus on the IPDAS position [3] it is appropriate to start with the 
conclusion from the latest Cochrane review, which was framed within it. “When people 
use decision aids, they improve their knowledge of the options (high-quality evidence) 
and feel better informed and more clear about what matters most to them (high-quality 
evidence). They probably have more accurate expectations of benefits and harms of 
options (moderate-quality evidence) and probably participate more in decision making 
(moderate-quality evidence). People who use decision aids may achieve decisions that 
are consistent with their informed values (evidence is not as strong; more research 
could change results). People and their clinicians were more likely to talk about the 
decision when using an aid. Decision aids have a variable effect on the option chosen, 
depending on the choice being considered. Decision aids do not worsen health 
outcomes, and people using them are not less satisfied. More research is needed to 
assess if people continue with the option they chose and also to assess what impact 
decision aids have on healthcare systems.“ [4] (p3). 
While of some interest, both these overall conclusions and the underlying meta-
analyses are of questionable benefit. It is hard to imagine any decision maker deciding 
whether or not to use ‘a decision aid’, any more than they would be deciding whether 
or not to prescribe ‘a drug’ or perform ‘an operation’. The meaningful decision is 
whether to use this or that or no decision aid - this or that type of drug or none, this or 
that type of surgery or none. So, it is the reports and assessments of the individual 
studies they review that are of real value. As implied in the overall conclusions, a wide 
range of ‘outcome’ criteria are reported in these and the way these are brought (or not 
brought) into the evaluation of a decision aid is preference-sensitive and interest-
conflicted. 
2. IPDAS on Decision Aid ‘Effectiveness’ 
Apart from developing its normative instrument, the International Patient Decision Aid 
Standards consortium has also published its preferences in relation to the empirical 
measurement of individual decision aid quality [3]. An umbrella concept is introduced 
– effectiveness – under which two separate constructs and measures are advanced. As 
before the purpose of quoting at length is to establish that preferences are clearly 
embedded in making this split, as well as in the selection of items and metrics. This is 
not made explicit in the presentation, which includes several ‘shoulds’. 
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“To establish the effectiveness of a PtDA [Patient Decision Aid], it is critical to 
provide evidence that the PtDA improves two constructs: i) the quality of the decision-
making process and ii) the quality of the choice that is made (i.e., ‘decision quality’)… 
For the quality of the decision-making process, the core attributes that should be 
measured include the extent to which PtDAs help patients to: • Recognize that a 
decision needs to be made (e.g., as measured by items in the Preparation for Decision 
Making Scale. • Feel informed about the options and about the risks, benefits, and 
consequences of the options (e.g. as measured by the “Feeling Uninformed” subscale 
of the Decisional Conflict Scale). • Be clear about what matters most to them for this 
decision (e.g. as measured by the “Unclear Values” subscale of the Decisional Conflict 
Scale. • Discuss goals, concerns, and preferences with their health care providers (e.g. 
as measured by items in the Perceived Involvement in Care Scale. • Be involved in 
decision making (e.g., as measured by the Control Preferences Scale and adaptations of 
it)… The quality of the choice that is made, or decision quality, is defined as the extent 
to which patients are informed and receive treatments that reflect their goals and 
treatment preferences. It follows from this construct definition that two core attributes 
should be measured: • Informed patient: This attribute is measured by assessing a 
patient’s knowledge of the options and outcomes. It is not assessed in terms of patient 
perceptions of their knowledge level; instead, factual items are used to assess 
objectively a patient’s understanding of the information. This may, when applicable, 
include an assessment of whether or not the patient holds realistic expectations of risks 
and benefits. • Concordance between what matters most to the patient and the chosen 
option: Most approaches to measuring this attribute require (1) the elicitation of a 
patient’s goals and/or treatment preferences; (2) the identification of the patient’s 
chosen or implemented option; and (3) a calculation of the extent to which the option 
best meets the patient’s stated goals or treatment preferences.”  [4] (p2) (italics 
supplied). 
3. Two Decision Quality Measures 
In the space available here we focus on the Decision Quality Instruments (DQIs), 
developed by members of the IPDAS consortium to measure ‘the quality of the choice 
that is made, or decision quality’, and on the Decision Conflict Scale which features 
heavily in their profile measure of the ‘quality of the decision making process’.  
As a profile measure, a DQI produces two scores. The DQI-Knowledge Score is 
the percentage of correct responses to a set of questions. A threshold for considering a 
patient to be ‘well-informed’ is set, using (if available) the mean knowledge score for a 
group of patients who have viewed a decision aid. The DQI-Concordance Score 
measures ‘the extent to which patients received treatments that reflected what is most 
important to them’. A binary Decision Quality Composite Score is created with a score 
of 1 for patients who were well-informed and received treatments matching their 
preferences, 0 for all others. The DQI composite score is only at the group level, 
available only after follow-up months after the decision, and being binary does not 
provide a scalar index measure. So DQIs are essentially research tools, not ones to be 
used in real time within clinical practice. They are not preference-sensitive index 
measures, assessed and available immediately after the point of decision, and before 
any deliberation occurs, any decision is taken, any actions engaged in, or outcomes 
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known. In all these respects they reflect interest-conflicted preferences orthogonal to 
ours. 
While the Decisional Conflict Scale may be a valid measure for the eponymous 
construct (i.e. decision conflict) - it lacks content validity for this task because of the 3 
items which make up its Uncertainty subscale. (‘This decision is easy for me to make’, 
‘I feel sure about what to choose’ and ‘I am clear about what choice is best for me’.) 
These penalize an aid that correctly reports the situation as one of decisional equipoise 
or near equipoise, a ‘false clarity’ bias being rewarded. In 20 of the Cochrane studies 
reporting all subscales, the Uncertainty score was 46% higher than the average of the 
other four in the decision aid arm, thereby reducing the effect of the decision aid 
relative to usual care. The 4-item SURE version of DCS is even more prone to this bias 
[5]. 
4. Discussion 
It is time to summarise our interest-conflicted preferences, scattered throughout the 
above, or only hinted at. Our preferred decision support tool displays a Decision 
Opinion as the expected value of each option, produced by applying the criterion 
weights of the decision owner to the performance ratings of each option on each 
criterion. Our (interest-conflicted) preference is for the quality of the tool to be 
measured at each use, empirically (not normatively) and comparatively, with genuine 
usual care as the mandatory comparator in order to avoid interest-conflicted Partial Or 
Non-Comparative Evaluation (PONCE) [6]. This measurement is to occur in the 
decision making setting immediately after engagement with the tool, in order that the 
tool’s Decision Opinion Quality is minimally confounded by any subsequent 
discussion or decision. The Decision Opinion Quality of the ‘usual care’ comparator is 
to be measured separately and independently, in maximal ignorance of the contents or 
Opinion of the tool, to further avoid bias from PONCE. Our (interest-conflicted) 
preferences for this quality assessment exclude, in agreement with Elwyn and Miron-
Shatz [7], any objective assessment of the knowledge of any party to the decision. 
(Apart from its unknown relevance in the decision, such a ‘knowledge’- assessing 
instrument is of a formative construct and therefore preference-sensitive and interest-
conflicted.) They also exclude, again in agreement with Elwyn and Miron-Shatz, all 
‘downstream’ outcomes of any sort, whether they relate to the health consequences of 
actions taken as a result of the eventual decision, or any later psychological/affective 
effects such as experienced regret. (Anticipated regret is assumed to be a key input into 
criterion weighting). Finally, they exclude any concern with the extent to which any 
elicited intention, or subsequent behaviour ‘matches’ the values expressed by the user 
during engagement with the tool.  
Historically, there was passing interest in PtDAs based on Decision Analysis - 
Dolan 2002 [8], Montgomery 2003 [9], Bekker 2004 [10] - which came close to 
meeting the above preferences. These Cochrane-included trials had positive outcomes, 
but the reported ‘obstacles’ in delivery and clinician acceptance undoubtedly 
contributed to their demise, along with paternalistic projection on to patients: ‘… there 
are concerns that encouraging individuals to adopt this more systematic approach to 
making choices places an additional burden on the decision process that may lead to 
greater distress, decisional conflict and post-choice regret.’ [10] (p266). As seen above, 
our preferences rule out decision conflict and post-choice regret as relevant criteria. 
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Potential ‘distress’ becomes a criterion for the decision owner to weight in deciding 
whether or not to engage with ‘a systematic process’. 
5. Conclusion 
Non-financial interest-conflicted preferences are endemic in healthcare research, 
policy-making and practice. The fact that they are essential, as well as inevitable, 
means that the problem lies in their denial or disguise. Paradoxically, much high-
quality research into decision support is undertaken by researchers hostile to positivist 
methodologies. But implying that a formative construct is reflective, or can be treated 
as such, because it embodies widely-supported preferences in line with current 
practices, is essentially positivistic. This needs to be explicitly acknowledged. Spelling 
out our preferred measure for evaluating decision aids, or introducing other non-IPDAS 
measures, has not been the aim. It is limited to establishing that a ‘level playing field’ 
must acknowledge that all quality measures are preference-sensitive and interest-
aligned, if not interest-conflicted. The preservation of existing structures and practices 
in healthcare research and provision may not be an interest embedded in some 
alternative constructs and measures of decision aid quality. 
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